IART Stock Recent News
IART LATEST HEADLINES
Integra (IART) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Integra (IART) is set to recommence the manufacturing of PriMatrix and SurgiMend at its new facility in Braintree, MA.
The company plans on operationalizing this new state-of-the-art facility in the first half of 2026 The company plans on operationalizing this new state-of-the-art facility in the first half of 2026
Integra (IART) reported earnings 30 days ago. What's next for the stock?
Investors need to pay close attention to Integra LifeScience (IART) stock based on the movements in the options market lately.
PRINCETON, N.J., May 13, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Lea Knight, chief financial officer will present at the 2024 Bank of America Healthcare conference on Tuesday, May 14, 2024 at 4:40pm ET.
Examine the evolution of Integra's (IART) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.
Strong demand for Integra's (IART) diverse portfolio of leading brands and continued successful market adoption of CereLink contributes to its revenues.
The headline numbers for Integra (IART) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
PRINCETON, N.J., April 18, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today announced that it has rescheduled the release of the Company's first quarter 2024 financial results to Monday, May 6, 2024. In conjunction with the earnings release, Integra's management team will host a conference call at 8:30 a.m. EDT.